vs
BIOLIFE SOLUTIONS INC(BLFS)与TRANSACT TECHNOLOGIES INC(TACT)财务数据对比。点击上方公司名可切换其他公司
BIOLIFE SOLUTIONS INC的季度营收约是TRANSACT TECHNOLOGIES INC的1.6倍($18.8M vs $11.5M),BIOLIFE SOLUTIONS INC同比增速更快(24.3% vs 11.9%),过去两年TRANSACT TECHNOLOGIES INC的营收复合增速更高(3.5% vs 1.0%)
BIOLIFE SOLUTIONS INC专注于开发生物保存产品及冷链管理解决方案,服务于细胞与基因治疗、生物制药及再生医学领域,产品涵盖低温保存培养基、自动化解冻系统、温度监测工具,为全球相关企业、科研机构及临床实验室提供支持。
该公司相关归属主体罗珀技术公司是一家控股集团,主要投资控股科技领域的各类企业,业务覆盖多个科技细分赛道,依托旗下子公司开展多元化科技业务布局。
BLFS vs TACT — 直观对比
营收规模更大
BLFS
是对方的1.6倍
$11.5M
营收增速更快
BLFS
高出12.4%
11.9%
两年增速更快
TACT
近两年复合增速
1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $18.8M | $11.5M |
| 净利润 | $11.1M | — |
| 毛利率 | — | 47.6% |
| 营业利润率 | 7.2% | -10.1% |
| 净利率 | 58.9% | — |
| 营收同比 | 24.3% | 11.9% |
| 净利润同比 | -11.1% | — |
| 每股收益(稀释后) | $0.23 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BLFS
TACT
| Q4 25 | $18.8M | $11.5M | ||
| Q3 25 | $28.1M | $13.2M | ||
| Q2 25 | $25.4M | $13.8M | ||
| Q1 25 | $23.9M | $13.1M | ||
| Q4 24 | $15.1M | $10.2M | ||
| Q3 24 | $21.4M | $10.9M | ||
| Q2 24 | $19.7M | $11.6M | ||
| Q1 24 | $18.4M | $10.7M |
净利润
BLFS
TACT
| Q4 25 | $11.1M | — | ||
| Q3 25 | $621.0K | $15.0K | ||
| Q2 25 | $-15.8M | $-143.0K | ||
| Q1 25 | $-448.0K | $19.0K | ||
| Q4 24 | $12.5M | — | ||
| Q3 24 | $-1.7M | $-551.0K | ||
| Q2 24 | $-20.7M | $-319.0K | ||
| Q1 24 | $-10.2M | $-1.0M |
毛利率
BLFS
TACT
| Q4 25 | — | 47.6% | ||
| Q3 25 | — | 49.8% | ||
| Q2 25 | — | 48.2% | ||
| Q1 25 | — | 48.7% | ||
| Q4 24 | — | 44.2% | ||
| Q3 24 | — | 48.1% | ||
| Q2 24 | — | 52.7% | ||
| Q1 24 | — | 52.6% |
营业利润率
BLFS
TACT
| Q4 25 | 7.2% | -10.1% | ||
| Q3 25 | -0.3% | 0.1% | ||
| Q2 25 | -65.5% | -1.9% | ||
| Q1 25 | -5.1% | -0.1% | ||
| Q4 24 | 3.6% | -10.3% | ||
| Q3 24 | -2.0% | -7.7% | ||
| Q2 24 | -6.6% | -3.8% | ||
| Q1 24 | -17.9% | -12.2% |
净利率
BLFS
TACT
| Q4 25 | 58.9% | — | ||
| Q3 25 | 2.2% | 0.1% | ||
| Q2 25 | -62.3% | -1.0% | ||
| Q1 25 | -1.9% | 0.1% | ||
| Q4 24 | 82.5% | — | ||
| Q3 24 | -8.0% | -5.1% | ||
| Q2 24 | -105.1% | -2.8% | ||
| Q1 24 | -55.4% | -9.7% |
每股收益(稀释后)
BLFS
TACT
| Q4 25 | $0.23 | $-0.11 | ||
| Q3 25 | $0.01 | $0.00 | ||
| Q2 25 | $-0.33 | $-0.01 | ||
| Q1 25 | $-0.01 | $0.00 | ||
| Q4 24 | $0.27 | $-0.80 | ||
| Q3 24 | $-0.04 | $-0.06 | ||
| Q2 24 | $-0.45 | $-0.03 | ||
| Q1 24 | $-0.22 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $33.0M | $20.4M |
| 总债务越低越好 | $5.0M | — |
| 股东权益账面价值 | $371.9M | $31.1M |
| 总资产 | $405.9M | $44.8M |
| 负债/权益比越低杠杆越低 | 0.01× | — |
8季度趋势,按日历期对齐
现金及短期投资
BLFS
TACT
| Q4 25 | $33.0M | $20.4M | ||
| Q3 25 | $29.5M | $20.0M | ||
| Q2 25 | $31.9M | $17.7M | ||
| Q1 25 | $66.9M | $14.2M | ||
| Q4 24 | $91.5M | $14.4M | ||
| Q3 24 | $24.0M | $11.3M | ||
| Q2 24 | $22.0M | $11.1M | ||
| Q1 24 | $29.7M | $10.6M |
总债务
BLFS
TACT
| Q4 25 | $5.0M | — | ||
| Q3 25 | $7.5M | — | ||
| Q2 25 | $10.1M | — | ||
| Q1 25 | $12.9M | — | ||
| Q4 24 | $15.9M | — | ||
| Q3 24 | $20.1M | — | ||
| Q2 24 | $21.1M | — | ||
| Q1 24 | $24.3M | — |
股东权益
BLFS
TACT
| Q4 25 | $371.9M | $31.1M | ||
| Q3 25 | $353.7M | $31.8M | ||
| Q2 25 | $347.2M | $31.3M | ||
| Q1 25 | $352.6M | $30.9M | ||
| Q4 24 | $348.9M | $30.6M | ||
| Q3 24 | $325.5M | $38.4M | ||
| Q2 24 | $321.4M | $38.5M | ||
| Q1 24 | $333.4M | $38.6M |
总资产
BLFS
TACT
| Q4 25 | $405.9M | $44.8M | ||
| Q3 25 | $392.1M | $45.0M | ||
| Q2 25 | $387.2M | $44.5M | ||
| Q1 25 | $395.1M | $44.2M | ||
| Q4 24 | $399.5M | $44.0M | ||
| Q3 24 | $381.7M | $50.5M | ||
| Q2 24 | $375.0M | $50.4M | ||
| Q1 24 | $401.6M | $51.9M |
负债/权益比
BLFS
TACT
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.02× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $4.9M | $609.0K |
| 自由现金流经营现金流 - 资本支出 | — | $589.0K |
| 自由现金流率自由现金流/营收 | — | 5.1% |
| 资本支出强度资本支出/营收 | — | 0.2% |
| 现金转化率经营现金流/净利润 | 0.44× | — |
| 过去12个月自由现金流最近4个季度 | — | $7.6M |
8季度趋势,按日历期对齐
经营现金流
BLFS
TACT
| Q4 25 | $4.9M | $609.0K | ||
| Q3 25 | $6.1M | $3.6M | ||
| Q2 25 | $7.4M | $3.6M | ||
| Q1 25 | $1.7M | $-161.0K | ||
| Q4 24 | $1.6M | $2.4M | ||
| Q3 24 | $4.8M | $327.0K | ||
| Q2 24 | $6.5M | $636.0K | ||
| Q1 24 | $-4.5M | $-1.5M |
自由现金流
BLFS
TACT
| Q4 25 | — | $589.0K | ||
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $-171.0K | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | — | $259.0K | ||
| Q2 24 | — | $499.0K | ||
| Q1 24 | — | $-1.6M |
自由现金流率
BLFS
TACT
| Q4 25 | — | 5.1% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 25.9% | ||
| Q1 25 | — | -1.3% | ||
| Q4 24 | — | 23.2% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | — | -14.9% |
资本支出强度
BLFS
TACT
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 1.0% |
现金转化率
BLFS
TACT
| Q4 25 | 0.44× | — | ||
| Q3 25 | 9.83× | 242.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -8.47× | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图